Mesoblast (MESO) Consolidated Net Income (2015 - 2023)

Mesoblast (MESO) has 9 years of Consolidated Net Income data on file, last reported at -$142.2 million in Q2 2023.

• For the quarter ending Q2 2023, Consolidated Net Income rose 11.57% year-over-year to -$142.2 million; the trailing twelve-month figure through Dec 2024 stood at -$142.2 million (down 43.62% YoY), and the FY2025 full-year result was -$102.1 million, down 16.13% from the prior year.
• Consolidated Net Income declined to -$142.2 million in Q2 2023, from $18.6 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $26.1 million in Q4 2021 to a low of -$160.9 million in Q2 2022.
• A 5-year average of -$21.2 million and a median of -$21.4 million in 2019 frame the typical range for Consolidated Net Income.
• Across the five-year window, Consolidated Net Income jumped 201.61% in 2021 and sank 629.19% in 2022, its largest moves.
• Tracing MESO's Consolidated Net Income over 5 years: stood at -$24.6 million in 2019, then slipped by 4.51% to -$25.7 million in 2020, then jumped by 201.61% to $26.1 million in 2021, then declined by 5.93% to $24.6 million in 2022, then slumped by 679.24% to -$142.2 million in 2023.
• Business Quant data shows MESO's Consolidated Net Income at -$142.2 million in Q2 2023, $18.6 million in Q1 2023, and $24.6 million in Q4 2022.